Skip to main content
. Author manuscript; available in PMC: 2016 Jun 30.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2015 May 2;93(1):158–165. doi: 10.1016/j.ijrobp.2015.04.047

Table 3.

Univariate Analysis of Factors Potentially Affecting Actuarial Rates of Intra-abdominal Recurrence and Distant Metastatic Free Survival Rates at 5 years

Variable Intra-abdominal
Recurrence Rate
at 5-year, %
Intra-abdominal
Recurrence
P Value
DMFS
5-year rate, %
DMFS
P value
Age
  > 65 62 0.047 73 0.48
  ≤ 65 40 68
Tumor Size
  > 5 cm 42 0.13 70 0.51
  ≤ 5 cm 65 62
De Novo at presentation
  Yes 31 <0.001 66 0.28
  No 76 78
Histology
  Liposarcoma 54 0.008 84 0.08
  Other 39 61
Grade
  High 46 0.32 60 0.003
  Intermediate 40 81
  Low 41 94
Margin Status
  Positive/Uncertain 58 0.003 70 0.86
  Negative 30 68
Treatment Plan
  Preop RT 44 0.60 70 0.62
  Postop RT 47 68
Radiation Dose
  > 50 Gy 43 0.85 67 0.71
  ≤ 50 Gy 49 57
IORT
  Yes 44 0.82 67 0.46
  No 45 70
Neo or Adj. Chemo
  Yes 37 0.38 71 0.98
  No 51 67
Concurrent Chemoradiation
  Yes 45 0.96 50 0.02
  No 44 72

Abbreviations: DMFS, distant metastatic free survival; RT, radiation therapy; IORT, intraoperative radiation therapy; Neo/Adj, neoadjuvant/adjuvant.